TNF and pulmonary arterial hypertension: Furthermore, we identify the mechanism by which TNFα, against a background of BMPR2 genetic loss-of-function, promotes the development of PAH by driving inappropriate PASMC proliferation through c-SRC family members and dysregulated NOTCH2/3 signalling.